Ahngook signs drug deal with Takeda Korea

Published: 2012-08-30 06:57:00

Updated: 2012-08-30 06:57:00

Ahngook Pharmaceutical said Tuesday it has signed an agreement with Takeda Korea in a move to exclusively distribute the latter’s Zycomb nasal spray solution here.

Zycomb is a combination medicinal product consisting of two different substances (ipratropium bromide + xylometazoline hydrochlori...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK